ASO Author Reflections: An Optimal Biological Model for Successful Drug Discovery

  • V. Craig JordanEmail author
ASO Author Reflections



V. Craig Jordan has no conflicts of interest to disclose.


  1. 1.
    Baumler E, Ehrlich P. Scientist for life. New York: Holmes B. Meyer; 1984.Google Scholar
  2. 2.
    Jordan VC. Scientific Survival Suggestions (Appendix 1). In: Jordan VC, editor. Estrogen action, selective estrogen receptor modulators and women’s health: progress and promise. London: Imperial College Press; 2013. p. 459–64.CrossRefGoogle Scholar
  3. 3.
    Jordan VC. Selective estrogen receptor modulation: a personal perspective. Cancer Res. 2003;61:5683–7.Google Scholar
  4. 4.
    Maximov PY, McDaniel RE, Jordan VC. Tamoxifen: milestones in drug therapy. Basel: Springer; 2013.Google Scholar
  5. 5.
    Jordan VC. The SERM saga, something from nothing: American Cancer Society/SSO basic science lecture. Ann Surg Oncol. Epub 25 Mar 2019.
  6. 6.
    Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol. 2013;8:135–55.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations